Literature DB >> 16824729

Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortex.

Jose Javier Miguel-Hidalgo1, Sorcha Nithuairisg, Craig Stockmeier, Grazyna Rajkowska.   

Abstract

Neurological and psychiatric alterations during aging are associated with increased cerebrovascular disturbances and inflammatory markers such as Intercellular Adhesion Molecule-1 (ICAM-1). We investigated whether the distribution of ICAM-1 immunoreactivity (ICAM-1-I) in histological sections from the left orbitofrontal cortex (ORB) was altered during normal aging. Postmortem tissue from the ORB of nine younger (27-54 years old) and 10 older (60-86) human subjects was collected. Cryostat sections were immunostained only with antibodies to ICAM-1 or together with an antibody to glial fibrillary acidic protein (GFAP). The total area fraction of ICAM-1-I, and the fraction of vascular and extravascular ICAM-1-I were quantified in the gray matter. Furthermore, we examined the association of extravascular ICAM-1-I to GFAP immunoreactive (GFAP-IR) astrocytes. In all subjects, brain blood vessels were similarly ICAM-1 immunoreactive, and in some subjects there was a variable number of extravascular patches of ICAM-1-I. The area fraction of ICAM-1-I was 120% higher (p<.0001) in the old subjects than in the young subjects. This increase localized mostly to the extravascular ICAM-1-I in register with GFAP-IR astrocytes. A much smaller, also age-dependent increase occurred in vascular ICAM-1-I. Our results indicate a dramatic increase in extravascular ICAM-1-I associated to GFAP-IR astrocytes in the ORB in normal aging. This increase may contribute to an enhanced risk for brain inflammatory processes during aging, although a role of extravascular ICAM-1 as a barrier to further inflammation cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824729      PMCID: PMC2921168          DOI: 10.1016/j.bbi.2006.05.001

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  66 in total

1.  Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry.

Authors:  Danielle J Tisserand; Jens C Pruessner; Ernesto J Sanz Arigita; Martin P J van Boxtel; Alan C Evans; Jelle Jolles; Harry B M Uylings
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Cytokines and the ageing brain.

Authors:  Colm Cunningham; Jan-Pieter Konsman; Tammy Cartmell
Journal:  Trends Neurosci       Date:  2002-11       Impact factor: 13.837

3.  Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly.

Authors:  Alan J Thomas; I Nicol Ferrier; Rajesh N Kalaria; Sue Davis; John T O'Brien
Journal:  Br J Psychiatry       Date:  2002-08       Impact factor: 9.319

4.  Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease.

Authors:  E M Frohman; T C Frohman; S Gupta; A de Fougerolles; S van den Noort
Journal:  J Neurol Sci       Date:  1991-11       Impact factor: 3.181

5.  Plasma cytokine profiles in elderly humans.

Authors:  R J Forsey; J M Thompson; J Ernerudh; T L Hurst; J Strindhall; B Johansson; B-O Nilsson; A Wikby
Journal:  Mech Ageing Dev       Date:  2003-04       Impact factor: 5.432

6.  Brain aging in normal Egyptians: cognition, education, personality, genetic and immunological study.

Authors:  Osamah Elwan; Obsis Madkour; Fadia Elwan; Mervat Mostafa; Azza Abbas Helmy; Maged Abdel-Naseer; Sanaa Abdel Shafy; Nervana El Faiuomy
Journal:  J Neurol Sci       Date:  2003-07-15       Impact factor: 3.181

7.  Smaller orbital frontal cortex volumes associated with functional disability in depressed elders.

Authors:  Warren D Taylor; David C Steffens; Douglas R McQuoid; Martha E Payne; Shwu-Hua Lee; Te-Jen Lai; K Ranga Rama Krishnan
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

Review 8.  Vascular cell senescence and vascular aging.

Authors:  Tohru Minamino; Hideyuki Miyauchi; Toshihiko Yoshida; Kaoru Tateno; Takeshige Kunieda; Issei Komuro
Journal:  J Mol Cell Cardiol       Date:  2004-02       Impact factor: 5.000

9.  Left orbital frontal cortex volume and performance on the benton visual retention test in older depressives and controls.

Authors:  David C Steffens; Douglas R McQuoid; Kathleen A Welsh-Bohmer; K Ranga Rama Krishnan
Journal:  Neuropsychopharmacology       Date:  2003-12       Impact factor: 7.853

10.  Neurokinin-1 receptors are decreased in major depressive disorder.

Authors:  Craig A Stockmeier; Xiaochun Shi; Lisa Konick; James C Overholser; George Jurjus; Herbert Y Meltzer; Lee Friedman; Pierre Blier; Grazyna Rajkowska
Journal:  Neuroreport       Date:  2002-07-02       Impact factor: 1.837

View more
  14 in total

Review 1.  The effect of aging on brain barriers and the consequences for Alzheimer's disease development.

Authors:  Nina Gorlé; Caroline Van Cauwenberghe; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mamm Genome       Date:  2016-05-03       Impact factor: 2.957

2.  Abnormal levels of vascular endothelial biomarkers in schizophrenia.

Authors:  Tanya T Nguyen; Sheena I Dev; Guanqing Chen; Sharon C Liou; Averria Sirkin Martin; Michael R Irwin; Judith E Carroll; Xin Tu; Dilip V Jeste; Lisa T Eyler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-09-23       Impact factor: 5.270

3.  Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury.

Authors:  Rodney M Ritzel; Joshua Crapser; Anita R Patel; Rajkumer Verma; Jeremy M Grenier; Anjali Chauhan; Evan R Jellison; Louise D McCullough
Journal:  J Immunol       Date:  2016-03-09       Impact factor: 5.422

4.  Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes.

Authors:  Jose Javier Miguel-Hidalgo; James C Overholser; George J Jurjus; Herbert Y Meltzer; Lesa Dieter; Lisa Konick; Craig A Stockmeier; Grazyna Rajkowska
Journal:  J Affect Disord       Date:  2011-05-04       Impact factor: 4.839

Review 5.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

6.  Capturing T Lymphocytes' Dynamic Interactions With Human Neural Cells Using Time-Lapse Microscopy.

Authors:  Florent Lemaître; Ana Carmena Moratalla; Negar Farzam-Kia; Yves Carpentier Solorio; Olivier Tastet; Aurélie Cleret-Buhot; Jean Victor Guimond; Elie Haddad; Nathalie Arbour
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

7.  Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment.

Authors:  Mina Elahy; Connie Jackaman; John Cl Mamo; Virginie Lam; Satvinder S Dhaliwal; Corey Giles; Delia Nelson; Ryusuke Takechi
Journal:  Immun Ageing       Date:  2015-03-07       Impact factor: 6.400

8.  CaSR Antagonist (Calcilytic) NPS 2143 Hinders the Release of Neuroinflammatory IL-6, Soluble ICAM-1, RANTES, and MCP-2 from Aβ-Exposed Human Cortical Astrocytes.

Authors:  Anna Chiarini; Ubaldo Armato; Peng Hu; Ilaria Dal Prà
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

9.  Systematic Analysis of Gene Expression Profiles Controlled by hnRNP Q and hnRNP R, Two Closely Related Human RNA Binding Proteins Implicated in mRNA Processing Mechanisms.

Authors:  Sara Cappelli; Maurizio Romano; Emanuele Buratti
Journal:  Front Mol Biosci       Date:  2018-08-30

10.  Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose.

Authors:  Qun Shan; Jun Lu; Yuanlin Zheng; Jing Li; Zhong Zhou; Bin Hu; Zifeng Zhang; Shaohua Fan; Zhen Mao; Yong-Jian Wang; Daifu Ma
Journal:  J Biomed Biotechnol       Date:  2009-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.